Stock listing

NASDAQ:HRTX Heron Therapeutics, Inc. Stock

Home listing (NASDAQ) of Heron Therapeutics, Inc.

Follow Heron Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:HRTX

$0.377 USD +0.015 (+4.0%)

Close on Oct 15, 2026

Heron Therapeutics, Inc. logo
Ticker
NASDAQ:HRTX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Heron Therapeutics (NASDAQ:HRTX) Q2 2026 Earnings Call

    Mon, Aug 10, 2026 · 8:30 AM ET

    Watch Transcript

  • Heron Therapeutics (NASDAQ:HRTX) Q1 2026 Earnings Call

    Mon, May 11, 2026 · 8:30 AM ET

    Watch Transcript

  • Heron Therapeutics (NASDAQ:HRTX) Q4 2025 Earnings Call

    Thu, Feb 26, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Heron Therapeutics Announces Second Quarter 2026 Financial Results

Aug 10, 2026

Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026

Jul 27, 2026

U.S. District Court Issues Decision Regarding CINVANTI® Patents

Jun 2, 2026

Heron Therapeutics Announces First Quarter 2026 Financial Results and Reaffirms Guidance

May 11, 2026

Heron Therapeutics to Report First Quarter 2026 Financial Results on Monday, May 11, 2026

Apr 27, 2026

Heron Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results

Feb 26, 2026

Heron Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 26, 2026

Feb 17, 2026

Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue; ZYNRELEF® Largest Contributor to Q4 Growth

Jan 9, 2026

Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)

Dec 4, 2025

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress

Nov 4, 2025

All Heron Therapeutics, Inc. news

Decks

Heron Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
12 in the last 12 months · 143 in all · newest Aug 10, 2026 · oldest 2019
Calls
20 calls with a replay · 20 with a transcript · latest Aug 10, 2026
Decks
35 decks · latest May 11, 2026

Where Heron Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:HRTX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:HRTXBOATSUnited StatesUSD
Lang & Schwarz:A1XB6KLang & SchwarzGermanyEUR
LS Exchange:A1XB6KLS ExchangeGermanyEUR
LSE:0J4VLSEUnited KingdomUSD
Stuttgart:AXD2StuttgartGermanyEUR
gettex:AXD2gettexGermanyEUR
Dusseldorf:AXD2DusseldorfGermanyEUR
Frankfurt:AXD2FrankfurtGermanyEUR
Tradegate:AXD2TradegateGermanyEUR
BX Swiss:AXD2BX SwissSwitzerlandCHF
Munich:AXD2MunichGermanyEUR

Log in to ask 6ix AI your own questions about Heron Therapeutics, Inc.